FDA approves Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema – Roche
Roche announced that the FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema (DME), a leading cause of vision loss in adults… read more.
